Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Peptic Ulcer Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
Global Peptic Ulcer Testing Market to Reach $717.9 Million by 2027
In the changed post COVID-19 business landscape, the global market for Peptic Ulcer Testing estimated at US$477 Million in the year 2020, is projected to reach a revised size of US$717.9 Million by 2027, growing at a CAGR of 6% over the analysis period 2020-2027.
Laboratory Tests, one of the segments analyzed in the report, is projected to record a 6.6% CAGR and reach US$375.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Upper Endoscopy segment is readjusted to a revised 5.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $139.5 Million, While China is Forecast to Grow at 5.6% CAGR
The Peptic Ulcer Testing market in the U.S. is estimated at US$139.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$126.2 Million by the year 2027 trailing a CAGR of 5.6% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.7% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.
Gastrointestinal Endoscopy Segment to Record 5.1% CAGR
In the global Gastrointestinal Endoscopy segment, USA, Canada, Japan, China and Europe will drive the 5.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$69.3 Million in the year 2020 will reach a projected size of US$98.4 Million by the close of the analysis period.
China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$82.4 Million by the year 2027.
What`s New for 2022?
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
| Report Attribute | Details |
| No. of Pages | 193 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value (USD) in 2020 | $477 Million |
| Forecasted Market Value (USD) by 2027 | $717.9 Million |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Peptic Ulcer Disease - A Global Phenomenon
- Recent Market Activity
- H. Pylori Infection: The Root Cause of Peptic Ulcer Disease
- Diagnosis of Peptic Ulcer Disease - Testing for H. Pylori Infection
- Market Outlook
- Developing Countries Lead Peptic Ulcer Testing Market
- Rising Incidence of Gastric Cancer: Potential Opportunities for H. Pylori Testing
- WHO Promotes H. Pylori Screening to Prevent Gastric Cancer-Related Deaths
- Competitive Scenario
- Select H. Pylori Diagnostic Tests/Test Kits Available in the Market
- A Review of Select H. Pylori Tests
- HeliprobeT Systems
- QuickVue H. pylori gII test
- CLOtest Rapid Urease Test
- EZ-H.P. (Bulk) and EZ-H.P. (Professional)
- BreathID Lab System
- Peptic Ulcer Testing - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS(Total 41 Featured)
- Becton, Dickinson and Company (US)
- Beckman Coulter, Inc. (US)
- Biomerica, Inc. (US)
- Biohit Oyj (Finland)
- bioMerieux SA (France)
- Bio-Rad Laboratories, Inc. (US)
- DiaSorin S.p.A. (Italy)
- EKF Diagnostics (UK)
- Exalenz Bioscience Ltd. (Israel)
- Halyard Health, Inc. (US)
- Kibion AB (Sweden)
- Meridian Bioscience, Inc. (US)
- Otsuka America Pharmaceutical, Inc. (US)
- Orion Diagnostica Oy (Finland)
- Polymedco CDP, LLC (US)
- Quidel Corporation (US)
- Sekisui Diagnostics, LLC (US)
- Thermo Fisher Scientific, Inc. (US)
3. MARKET TRENDS & DRIVERS
- Sustained increase in Prevalence of Infectious Diseases Turns Focus onto Rapid Testing
- Higher Risk of H. pylori Disease Raises Demand for Testing from Elderly Population
- Differential Accuracy of Diagnostic Tests in Adults and Children
- Rapid Tests - Enabling Faster Testing for H. Pylori Infection
- Rapid Urease Tests: Most Useful Invasive Test for H. Pylori Detection
- Urea Breath Test - A Gold Standard in Non-Invasive Tests
- Availability of Tests Influences Market Adoption
- Cost Influencing Choice of Testing for H. Pylori
- Recommendations for H. Pylori Diagnostic Tests - An Overview
- Diagnostic Methods for H. Pylori Infection as Recommended by Guidelines in Select Countries
- Histology, UBT and SAT: Expensive Yet High-Value Offering Tests
- DVC-FISH Test Offers Positive Results in Detecting Viable H. Pylori Cells in Fecal Samples
- FIVH (fluorescence in vivo hybridization) - The New Kid on the Block
- Guidelines for Diagnosing H. Pylori Ulcers in Children
- Antibody Tests Not Recommended for Children; Biopsy Tests More Pertinent
4. GLOBAL MARKET PERSPECTIVE
III. REGIONAL MARKET ANALYSIS
IV. COMPETITION
For more information about this report visit https://www.researchandmarkets.com/r/nnm2pb
Attachment
